INR optimization based on stroke risk factors in patients with non-valvular atrial fibrillation.

about

Efficacy and Safety of Uninterrupted Low-Intensity Warfarin for Radiofrequency Catheter Ablation of Atrial Fibrillation in the Elderly.

P2860

Q48640243-7ADAC2CF-F2CD-4E48-83EA-1A303DE9E7A6

P2860

INR optimization based on stroke risk factors in patients with non-valvular atrial fibrillation.

Item

http://www.wikidata.org/entity/Q38525931

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

INR optimization based on stro ...... -valvular atrial fibrillation.

@en

type

Item

label

INR optimization based on stro ...... -valvular atrial fibrillation.

@en

prefLabel

INR optimization based on stro ...... -valvular atrial fibrillation.

@en

P1476

INR optimization based on stro ...... -valvular atrial fibrillation.

@en

P2093

Hye Sun Gwak

http://www.w3.org/2001/XMLSchema#string

Hyen O La

http://www.w3.org/2001/XMLSchema#string

Jee Eun Chung

http://www.w3.org/2001/XMLSchema#string

Jong Mi Seong

http://www.w3.org/2001/XMLSchema#string

Yoo Ri Choi

http://www.w3.org/2001/XMLSchema#string

P2860

Optimal INR for prevention of stroke and death in atrial fibrillation: a critical appraisal

Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial

2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study.

Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation.

Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Trends in Oral Anticoagulation Therapy Among Korean Patients With Atrial Fibrillation: The KORean Atrial Fibrillation Investigation.

Is INR between 2.0 and 3.0 the optimal level for Chinese patients on warfarin therapy for moderate-intensity anticoagulation?

P2888

s11096-015-0149-5

P304

1038-1046

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11096-015-0149-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1015760618

http://www.w3.org/2001/XMLSchema#string

P698

26068570

http://www.w3.org/2001/XMLSchema#string

INR optimization based on stroke risk factors in patients with non-valvular atrial fibrillation.

about

P2860

P2860

INR optimization based on stroke risk factors in patients with non-valvular atrial fibrillation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698